These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3063850)

  • 21. [Recent trend of incidence of respiratory pathogenic bacteria and its susceptibility to antimicrobial agents: studies in the year 1984-1986].
    Nishioka K; Ogiwara H; Ida S; Takishima T
    Jpn J Antibiot; 1988 Sep; 41(9):1212-22. PubMed ID: 3149325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Laboratory and clinical studies on cefotetan in respiratory tract infections].
    Ida S; Nishioka K; Takishima T; Satoh S; Kikuta Y; Ohnami K; Yamaki M; Kimura H; Kudo K; Mori S
    Jpn J Antibiot; 1988 Apr; 41(4):415-26. PubMed ID: 3043035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bacteriological and clinical studies of flomoxef in the field of pediatrics].
    Kuno K; Nakao Y; Hayakawa F; Miura K; Miyajima Y; Ishikawa H; Kimura H
    Jpn J Antibiot; 1987 Aug; 40(8):1393-406. PubMed ID: 3430715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacokinetics and clinical studies of flomoxef in the pediatric field].
    Motohiro T; Oda K; Aramaki M; Kawakami A; Tanaka K; Koga T; Shimada Y; Tomita S; Sakata Y; Fujimoto T
    Jpn J Antibiot; 1987 Aug; 40(8):1515-34. PubMed ID: 3430727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacokinetical, bacteriological and clinical studies of flomoxef in the pediatric field].
    Iwai N; Miyazu M; Nakamura H; Katayama M; Kasai K; Taneda Y
    Jpn J Antibiot; 1987 Aug; 40(8):1377-91. PubMed ID: 3430714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Flomoxef treatment of patients with respiratory tract infections].
    Takagi K; Yamaki K; Satake T; Suzuki R; Kume H; Tsuzuki T; Matsumoto S; Horiba M; Hara M; Inoue K
    Jpn J Antibiot; 1987 Oct; 40(10):1787-93. PubMed ID: 3444018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Laboratory and clinical studies on flomoxef in neonates and premature infants].
    Motohiro T; Maruoka T; Nagai K; Oki S; Tsumura N; Sasaki H; Aramaki M; Koga T; Sakata Y; Tominaga K
    Jpn J Antibiot; 1993 Jul; 46(7):547-67. PubMed ID: 8371491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1998)].
    Ikemoto H; Arakawa M; Gejyo F; Igarashi K; Mori T; Okada M; Ozaki K; Igari J; Aoki N; Oguri T; Kitamura N; Terai T; Sekine O; Suzuki Y; Inoue H; Nakadate T; Karasawa Y; Ito C; Yoshida T; Nakata K; Nakatani T; Ohno I; Okada S; Inagawa H; Kudo K; Kobayashi N; Ando M; Suga M; Sato K; Kondo T; Tosaka M; Kobayashi H; Kawai S; Takayasu S; Kohno S; Tomono K; Shimada K; Nakano K; Miyazaki Y; Izumikawa K; Yamaguchi T; Mochida C; Yokouchi H; Ito A; Sumitomo M; Nasu M; Nagai H; Yamasaki T; Matsushima T; Nakano T
    Jpn J Antibiot; 2000 May; 53(5):261-98. PubMed ID: 10923284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2000)].
    Shimada K; Terai T; Igari J; Inoue H; Nakadate T; Oguri T; Suwabe A; Obata R; Ikemoto H; Ohno I; Okada S; Hayashi K; Mori T; Nakano K; Arakawa M; Gejyo F; Igarashi K; Yokouchi H; Okada M; Ito A; Sumitomo M; Aoki N; Matsushima T; Niki Y; Kitamura N; Suga M; Suzuki Y; Karasawa Y; Tosaka M; Nakata K; Nakatani T; Kohno S; Tomono K; Miyazaki Y; Inagawa H; Hirakata Y; Aoki S; Matsuda J; Kudo K; Kobayashi N; Kinoshita T; Konosaki H; Nasu M; Nagai H; Kobayashi H; Kawai S; Takayasu S; Hiramatsu K; Nakano T
    Jpn J Antibiot; 2002 Oct; 55(5):537-67. PubMed ID: 12532637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Nov; 48(11):1627-57. PubMed ID: 8558754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical studies of flomoxef in the field of pediatrics].
    Ito S; Mayumi M; Mikawa H
    Jpn J Antibiot; 1987 Aug; 40(8):1418-25. PubMed ID: 3430717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical studies of flomoxef in the pediatric field].
    Morimoto T; Kida K; Matsuda H; Murase M
    Jpn J Antibiot; 1987 Aug; 40(8):1486-95. PubMed ID: 3430724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antibiotic sensitivity of Branhamella catarrhalis isolated from respiratory tract infections].
    Nishioka K; Ida S; Takishima T
    Jpn J Antibiot; 1984 Jul; 37(7):1289-93. PubMed ID: 6567671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of cefuzonam in the pediatric field].
    Nakazawa S; Sato H; Narita A; Matsumoto K; Suzuki H; Nakazawa S; Chikaoka H; Koido R; Kamigaki M; Nakada Y
    Jpn J Antibiot; 1987 Mar; 40(3):613-29. PubMed ID: 3613082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacokinetics and clinical studies on flomoxef in neonates and premature infants. A study of flomoxef in the perinatal collaboration research group].
    Fujii R; Fujita K; Murono K; Saijo M; Kakuya F; Yoshioka H; Maruyama S; Sakata H; Hiramoto A; Inyaku F
    Jpn J Antibiot; 1993 Jul; 46(7):518-38. PubMed ID: 8371489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical evaluation of cefixime in pediatric respiratory tract infections].
    Iwai N; Nakamura H; Kasai K; Ozaki T; Matsui Y; Tauchi N; Yamaguchi H; Taneda Y; Maki T
    Jpn J Antibiot; 1991 Jan; 44(1):35-47. PubMed ID: 2041146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Laboratory and clinical evaluations of flomoxef sodium in neonates].
    Iwai N; Nakamura H; Miyazu M; Kasai K; Watanabe Y; Taneda Y; Ozaki T; Matsui S; Maki T; Tauchi N
    Jpn J Antibiot; 1991 Nov; 44(11):1265-85. PubMed ID: 1784077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Fujime M; Fujita K; Shigeta S; Watanabe J; Igari J; Ogiwara M; Ishibashi K; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Matsumoto T; Kashitani F; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Mochida C
    Jpn J Antibiot; 1999 Feb; 52(2):93-129. PubMed ID: 10221177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.